We are live on ! Find out more
BG

Bollard Group Portfolio holdings

AUM $3.39B
1-Year Est. Return 1.06%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
-1.06%
3 Year Est. Return
+72.63%
5 Year Est. Return
+112.03%
10 Year Est. Return
+415.67%
AUM
$4.37B
AUM Growth
+$566M
Cap. Flow
+$197M
Cap. Flow %
4.52%
Top 10 Hldgs %
75.62%
Holding
311
New
26
Increased
196
Reduced
22
Closed
17

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$25.9M
2
MSGS icon
Madison Square Garden
MSGS
+$23.3M
3
MSFT icon
Microsoft
MSFT
+$14.8M
4
AMZN icon
Amazon
AMZN
+$12.7M
5
NVDA icon
NVIDIA
NVDA
+$12.5M

Sector Composition

Rank Sector Weight
1 Healthcare 56.07%
2 Technology 8.45%
3 Energy 6.73%
4 Consumer Discretionary 4.64%
5 Utilities 4.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSI icon
151
Motorola Solutions
MSI
$69.4B
$466K 0.01%
1,107
+56
+5% +$23.4K
GENI icon
152
Genius Sports
GENI
$1.73B
$459K 0.01%
44,140
EXC icon
153
Exelon
EXC
$48.6B
$456K 0.01%
10,496
+86
+0.8% +$3.83K
BCE icon
154
BCE
BCE
$19.9B
$448K 0.01%
20,192
-8,066
-29% -$176K
UPS icon
155
United Parcel Service
UPS
$97.6B
$445K 0.01%
4,409
+143
+3% +$14.1K
ACVA icon
156
ACV Auctions
ACVA
$1.35B
$440K 0.01%
27,131
CINF icon
157
Cincinnati Financial
CINF
$28.3B
$431K 0.01%
2,891
+108
+4% +$15.5K
CSCO icon
158
Cisco
CSCO
$450B
$420K 0.01%
6,054
+317
+6% +$19.5K
ABBV icon
159
AbbVie
ABBV
$458B
$404K 0.01%
2,177
+102
+5% +$19K
CLDX icon
160
Celldex Therapeutics
CLDX
$2.77B
$399K 0.01%
+19,627
New +$382K
CB icon
161
Chubb
CB
$140B
$388K 0.01%
1,340
+50
+4% +$14.4K
CTVA icon
162
Corteva
CTVA
$59.7B
$376K 0.01%
5,040
+81
+2% +$5.4K
GIS icon
163
General Mills
GIS
$19.2B
$365K 0.01%
7,042
+312
+5% +$17.2K
MDT icon
164
Medtronic
MDT
$107B
$360K 0.01%
4,127
+33
+0.8% +$2.8K
AIG icon
165
American International
AIG
$41.9B
$356K 0.01%
4,162
+219
+6% +$18.2K
COIN icon
166
Coinbase
COIN
$41.7B
$350K 0.01%
+1,000
New +$234K
BRK.B icon
167
Berkshire Hathaway Class B
BRK.B
$1.07T
$321K 0.01%
660
STT icon
168
State Street
STT
$50.9B
$313K 0.01%
2,946
+167
+6% +$15.4K
FLYW icon
169
Flywire
FLYW
$1.96B
$300K 0.01%
25,609
DVN icon
170
Devon Energy
DVN
$51.9B
$297K 0.01%
9,340
-4,972
-35% -$158K
ABEO icon
171
Abeona Therapeutics
ABEO
$345M
$281K 0.01%
+49,393
New +$281K
XLV icon
172
State Street Health Care Select Sector SPDR ETF
XLV
$42.1B
$266K 0.01%
1,976
+8
+0.4% +$1.08K
GD icon
173
General Dynamics
GD
$105B
$264K 0.01%
904
+48
+6% +$13.2K
IBM icon
174
IBM
IBM
$202B
$236K 0.01%
800
INDB icon
175
Independent Bank
INDB
$4.05B
$227K 0.01%
3,613
+73
+2% +$4.44K

Similar funds

Bollard Group's Q2 2025 Portfolio in Review

As of Q2 2025, Bollard Group held 311 positions worth $4.37B, up 15% from $3.81B the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Bollard Group deployed $197M of net new capital in Q2 2025, opening 26 new positions and adding to 196 existing holdings. Its largest new stake was Madison Square Garden: 121,000 shares worth $25.3M.

By sector, the portfolio is most concentrated in Healthcare at 56% of assets, down from 61% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Boston Scientific, an estimated $41.6M trimmed.

  • Bollard Group's largest Q2 2025 buy was Madison Square Garden: 121,000 shares worth $25.3M.
  • Bollard Group added most to Thermo Fisher Scientific in Q2 2025, an estimated $25.9M increase.
  • Bollard Group's biggest Q2 2025 reduction was Boston Scientific, cutting an estimated $41.6M.
  • Bollard Group fully exited HF Sinclair in Q2 2025, selling an estimated $6.4M.
  • Bollard Group's ten largest holdings make up 76% of its $4.37B portfolio in Q2 2025.
  • Bollard Group opened 26 new positions and closed 17 in Q2 2025.
  • Bollard Group's portfolio value rose 15% quarter-over-quarter to $4.37B.

Based on Bollard Group's 13F filing for Q2 2025, filed 13 Aug 2025.